About Shennon Biotechnologies
Analyze, understand & manipulate immune cells on the single cell level to develop better treatments for human diseases
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- San Francisco, California
- Founded
- 2021
- Company type
- Privately Held
ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy. We utilize the platform to functionally profile immune cells and their cognate antigens and apply this knowledge to develop more effective therapies against solid tumors and autoimmune diseases. Based in San Francisco next to UCSF Mission Bay, we are funded by DCVC, Foundation Capital and AV8.
www.shennonbio.com
Specialties
- Single cell functional profiling
- Immunotherapy target discovery
- Ultra high throughput analysis
- More effective Immunotherapy
- and Curative treatments for solid tumors
Company locations
2325 3rd Street, San Francisco, California 94107, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 3,495
- People linked to this company
- 15
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.